Inspire Medical Systems (INSP) Cash from Operations (2017 - 2026)

Inspire Medical Systems has disclosed Cash from Operations across 10 years of filings, most recently posting $23.2 million for Q2 2026.

• In Q2 2026, Cash from Operations rose 765.42% year-over-year to $23.2 million; the TTM figure through Jun 2026 stood at $157.1 million (up 33.74% YoY), while the FY2025 annual figure was $117.0 million, down 10.19% from the prior year.
• Cash from Operations came in at $23.2 million for Q2 2026 at Inspire Medical Systems, up from $12.8 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $69.2 million in Q4 2024 to a low of -$12.7 million in Q1 2022.
• Average Cash from Operations over 5 years is $17.8 million, with a median of $9.9 million recorded in 2022.
• The largest YoY upside for Cash from Operations was 3541.03% in 2025 against a maximum downside of 175.65% in 2025.
• Over 5 years, Cash from Operations stood at $19.3 million in 2022, then dropped by 10.39% to $17.3 million in 2023, then soared by 300.65% to $69.2 million in 2024, then fell by 24.16% to $52.5 million in 2025, then slumped by 55.73% to $23.2 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were $23.2 million in Q2 2026, $12.8 million in Q1 2026, and $52.5 million in Q4 2025.